1. Home
  2. News & Events
  3. FDA Meetings, Conferences and Workshops
  4. Public Calendar - Meetings With FDA Officials
  5. Public Calendar: February 15 -21, 2026
  1. Public Calendar - Meetings With FDA Officials

Public Calendar: February 15 -21, 2026

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Martin A. Makary, M.D., M.P.H., Commissioner for Food and Drugs

Event Date: 02/17/2026
Location: Silver Spring, MD
Subject: Domestic Manufacturing of Critical Active Pharmaceutical Ingredients (APIs)
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Gatlan Health and NucareRx Pharmaceuticals repesentatives

Event Date: 02/17/2026
Location: Washington, DC
Subject: PhRMA Forum; Speaker: Fireside Chat
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Industry, academia, government, media, and other stakeholders

Event Date: 02/18/2026
Location: Silver Spring, MD
Subject: Opportunities for FDA and Industry Collaboration
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: David Ricks (Eli Lilly); James Stansel, Kelly Goldberg, Lucy Vereshchagina, Steve Ubl (PhRMA); Robert Davis (Merck and Co.);

Event Date: 02/19/2026
Location: Washington, DC
Subject: FDA’s Position on Regulatory Proposals
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Joe Lonsdale (8VC);

Event Date: 02/19/2026
Location: Washington, DC
Subject: Future of Pharmaceuticals CEO Summit; Speaker: Fireside Chat
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Pharmaceutical sector CEOs

Event Date: 02/19/2026
Location: Washington, DC
Subject: Book Release of We the Women: The Hidden Heros Who Shaped America
FDA Participant/Group: N/A
Non FDA Participant/Group: Widely attended gathering

Event Date: 02/20/2026
Location: Washington, DC
Subject: Research and Development Leader Forum
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Industry, academia, government, media, and other stakeholders

Official Name: Sara Brenner, M.D., M.P.H., Principal Deputy Commissioner for Food and Drugs

No Significant Event

Official Name: Sean R. Keveney, Chief Counsel

No Significant Event

Official Name: Grace Graham, Deputy Commissioner for Policy, Legislation, and International Affairs

No Significant Event

Official Name: Kyle Diamantas, J.D., Deputy Commissioner for Human Foods

Event Date: 02/17/2026
Location: Silver Spring, MD
Subject: Infant Formula Issues of Mutual Interest
FDA Participant/Group: RACHAEL SILKO; DONALD PRATER; ELIZABETH SCHULZ; ROBIN MCKINNON; REBECCA BUCKNER; 
Non FDA Participant/Group: Dylan McMahon, Luke Douglas, Ross McMahon, Will McMahon (Kendal Nutricare); John Ray (Jeffrey J. Kimbell and Associates);

Event Date: 02/17/2026
Location: College Park, MD
Subject: Food Ingredient and Safety Issues of Mutual Interest
FDA Participant/Group: LARRY MORRIS; MARK HARTMAN; LAURA PILLSBURY; KRISTI MULDOON JACOBS; DONALD PRATER; KIRK ARVIDSON; 
Non FDA Participant/Group: Health and Chemicals Coalition representatives

Event Date: 02/18/2026
Location: College Park, MD
Subject: Food Safety Issues of Mutual Interest 
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Safe Food Coalition representatives

Event Date: 02/19/2026
Location: College Park, MD
Subject: Leafy Greens Safety Issues of Mutual Interest
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Leafy Greens Safety Coalition representatives

Event Date: 02/19/2026
Location: College Park, MD
Subject: Listening Session: Botanical Kratom
FDA Participant/Group: LARRY MORRIS; CARA WELCH; 
Non FDA Participant/Group: Ashley Gunn (Miller Strategies); Paloma Lehfeldt, Sheldon Bradshaw (Botanicals for Better Health and Wellness); Andrew Kulpa (Global Extracts Inc.);

Event Date: 02/20/2026
Location: Silver Spring, MD
Subject: Introductory Meeting 
FDA Participant/Group: LARRY MORRIS; CARA WELCH; DONALD PRATER; 
Non FDA Participant/Group: Daniel Fabricant, Kyle Turk (Natural Products Association); Cate Thorin, Leah Buchman, Tue Micheelsen (Novonesis);

Event Date: 02/20/2026
Location: Silver Spring, MD
Subject: Ultra-Processed Foods
FDA Participant/Group: DONALD PRATER; LARRY MORRIS; MARK HARTMAN; 
Non FDA Participant/Group: Ashley Gearhardt (University of Michigan); Rachel Roller (Dohmen Company Foundation);

Official Name: Barclay Butler, Ph.D., Deputy Commissioner for Operations

No Significant Event

Official Name: Lowell Zeta, J.D., Deputy Commissioner for Strategic Initiatives

Event Date: 02/18/2026
Location: Silver Spring, MD
Subject: De-scheduling of the Dual Orexin Receptor Antagonists (DORA) Products
FDA Participant/Group: KARIM MIKHAIL; MARTA SOKOLOWSKA; LUKE HALL; 
Non FDA Participant/Group: Idorsia representatives

Event Date: 02/19/2026
Location: Virtual
Subject: New Plausible Mechanism Pathway 
FDA Participant/Group: KARIM MIKHAIL; BRIAN FAHEY; 
Non FDA Participant/Group: Grace Science LLC representatives

Official Name: Elizabeth Miller, Pharm.D., Associate Commissioner for Inspections and Investigations

Event Date: 02/20/2026
Location: Washington, DC
Subject: USP Global Dependencies in the Medicines Supply Chain: Assessing Risks to American Health Forum; Panelist: Assessing Risks and Building a More Resilient Supply of U.S. Medicines
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, academia, government, media, and other stakeholders

Official Name: Vinayak Prasad, M.D., M.P.H., Director, Center for Biologics and Research

No Significant Event

Official Name: Michelle Tarver, M.D., Ph.D., Director, Center for Devices and Radiological Health

Event Date: 02/17/2026
Location: Virtual
Subject: General Medical Device Updates 
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Oura Health representatives

Event Date: 02/18/2026
Location: Silver Spring, MD
Subject: General Medical Device Updates
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Philips representatives

Event Date: 02/19/2026
Location: Washington, DC
Subject: Milken Institute’s Women’s Health Network Coverage and Reimbursement Workshop; Panelist: Learnings from the Field: Success Stories and Challenges
FDA Participant/Group: COURTNEY LIAS; 
Non FDA Participant/Group: Industry, government, academia, and other stakeholders

Official Name: Tracy Beth Høeg M.D., Ph.D., Acting Director, Center for Drug Evaluation and Research

No Significant Event

Official Name: Bret Koplow, Ph.D., J.D., Acting Director, Center for Tobacco Products

No Significant Event

Official Name: Timothy Schell, Ph.D., Director, Center for Veterinary Medicine

Event Date: 02/17/2026
Location: College Park, MD
Subject: Veterinary Issues of Mutual Interest
FDA Participant/Group: WILLIAM FLYNN; 
Non FDA Participant/Group: Bill Bookout (National Animal Supplement Council (NASC)); Todd Harrison, William Nordwind (Venable LLP);

Back to Top